Pepsi Earnings vs. ...
Health Care: Drugs
SciClone Pharmaceuticals (SCLN: NASDAQ)
$5.10 -0.04 | -0.78%
02/09/12 - 04:00 PM ET
123.12K / 213.60K
Vol / Avg. Vol:5.18 / 5.14
Open / Prev. Close:5.07 - 5.20
Today's Range:3.30 - 6.88
52 Wk Range:19.81%
Performance YTD:TheStreet Rating:
Portfolios with SCLN
- Portfolio NameUser Type
- ContributorTop-Rated Biotechnology Stocks
- UserDivFive
- Contributor10 Pharma Stocks With 100% ...
- UserPicking Winners
- UserMicroCap Biotech/Pharma Sto...
- Userbiotech
- UserDaktowilly Portfolio 1
- UserHoneybun Portfolio 1
- UserThe Scotsman's Portfoliio
- UserMad Money 44
Latest SCLN Headlines from TheStreet
- SciClone Reaches New 52-Week High (SCLN) 07.14.11 | 10:07 am
- SciClone Stock Hits New 52-Week High (SCLN) 06.27.11 | 12:06 pm
- 10 Pharma Stocks With 100% Buy Ratings 02.03.11 | 11:02 am
- FedEx: Premarket Trading 12.16.10 | 08:12 am
- Bank of America: After-Hours Trading 12.15.10 | 06:12 pm
- Tavakoli's Take, Collectables, Schwab Bond ETFs 08.10.10 | 05:08 pm
- Stock Wrap: The Real Story, August 10
08.10.10 | 04:08 pm - Ambac, SciClone: Volume Movers 08.10.10 | 10:08 am
- Sino Clean Energy, Zale: Early Volume Plays 04.09.10 | 10:04 am
- SciClone, IncrediMail: Midday Volume Plays 03.25.10 | 12:03 pm
Press Releases for SCLN
- Kahn Swick & Foti, LLC Announce Continuing Investigation Into SciClone Pharmaceuticals, Inc. – Firm Appointed Co-lead Counsel In Securities Class Action – SCLN - Business Wire 11.02.10 | 06:11 pm
- Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against SciClone Pharmaceuticals, Inc. - Business Wire 09.23.10 | 10:09 am
- Ryan & Maniskas, LLP Announces Class Action Lawsuit Against SciClone Pharmaceuticals, Inc. - Business Wire 08.20.10 | 07:08 pm
- Kendall Law Group Investigates SciClone Pharmaceuticals, Inc. For Shareholders - Business Wire 08.20.10 | 01:08 pm
- Robbins Umeda LLP Announces Investigation Of SciClone Pharmaceuticals, Inc. - Business Wire 08.12.10 | 07:08 pm
- Finkelstein Thompson LLP Announces Investigation Of SciClone Pharmaceuticals, Inc. - Business Wire 08.11.10 | 04:08 pm
- Goldfarb Branham LLP Investigating SciClone Pharmaceuticals For Investors - Business Wire 08.11.10 | 12:08 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of SciClone Pharmaceuticals, Inc. - Business Wire 08.10.10 | 08:08 pm
- Levi & Korsinsky, LLP Investigates SciClone Pharmaceuticals, Inc. - Business Wire 08.10.10 | 08:08 pm
- Roy Jacobs & Associates Investigating SciClone Pharmaceuticals, Inc. For Possible Securities Law Violations ("SCLN") - Business Wire 08.10.10 | 05:08 pm
Partner Headlines for SCLN
- 2 $4 Stocks With Rapid Sales Growth That Are Heading Higher - Seeking Alpha 01.31.12 | 06:01 am
- Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales - Seeking Alpha 10.28.11 | 06:10 am
- 9 Stocks Trading Under $7 With Monster Upside Potential - Seeking Alpha 06.09.11 | 08:06 am
- SciClone: Novamed Acquisition Helps, But Questions Remain - Seeking Alpha 05.20.11 | 07:05 am
- 19 High Growth Micro Cap Stocks Under $10 - Seeking Alpha 01.23.11 | 07:01 am
- UPDATE 1-SciClone Pharma Q3 EPS beats, raises FY profit view - Reuters 11.08.10 | 05:11 pm
- Healthcare Headlines: Santarus Rallies, Amgen Announces Results - Seeking Alpha 10.06.10 | 08:10 am
- Drugmakers face scrutiny over payments - Financial Times 08.13.10 | 02:08 am
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on Aug 10 - Reuters 08.10.10 | 11:08 am
- UPDATE 1-SciClone Q1 profit tops Street, backs FY10 outlook - Reuters 05.06.10 | 05:05 pm
